Shardul Nautiyal, Mumbai Friday, April 4, 2025, 08:00 Hrs [IST] ...

IgM populations rise very quickly when the body is first confronted with an infectious organism, and then they plummet as IgG antibodies take over. IgM is also produced by B cells and, when bound to a ...

Dengue fever cases have been rising among U.S. travelers and are expected to climb this year, according to a warning from the Centers for Disease Control and Prevention (CDC). A “record number ...

Dana Schulz is an experienced editor, writer, and content strategist who is just as likely to be crunching the ...

Hospitals are witnessing a concerning rise in flu-like illnesses and dengue fever among children. There is an uptick in hospital admissions for those presenting with severe respiratory symptoms, fever ...

BACOLOD CITY, NEGROS OCCIDENTAL, Philippines — Dengue cases in Negros Occidental and this city continue to increase despite a stepped-up campaign to eliminate breeding places of mosquitoes ...

4. Regardless of symptom onset date, test patients with suspected dengue using RT-PCR or an NS1 antigen test, as well as an IgM enzyme-linked immunosorbent assay antibody test. 5. Be aware of ...

1 Department of Internal Medicine, College of Medical Sciences Teaching Hospital, Chitwan, Nepal 2 Department of Microbiology, College of Medical Sciences Teaching Hospital, Nepal Consider dengue in ...

“Every Filipino has a role in this fight against dengue. By maintaining cleanliness in our surroundings and being vigilant about early symptoms, we can protect our families and communities from ...

According to the World Health Organisation, dengue (break-bone fever) is a viral infection that spreads from mosquitoes to people. It is more common in tropical and subtropical climates.

MANILA, Philippines — Senator Nancy Binay sought the approval of a new generation dengue vaccine as she raised the need for the government to curb the rise of dengue in the country. In a statement on ...

In yet another early year blow for the Bay Area’s biotech workforce, IGM Biosciences is laying off almost three-fourths of its staff after a crucial clinical study delivered poor results.